Lilly Announces Fourth Quarter Dividend

The company's quarterly numbers aren't due until later this week, but here's a sign that the Zyprexa scandal isn't affecting Lilly's bottom line: the company just declared a dividend of 42.5 cents a share, the same as prior recent quarters (press release here). This despite a reported erosion of market share for Zyprexa.

More later this week.